The international scientific network now known as Cochrane (formerly the Cochrane Collaboration)—which every year churns out hundreds of influential systematic reviews geared toward health policy-making—is not the type of organization that typically makes news headlines. Of late, however, Cochrane’s vaunted edifice of credibility has been visibly crumbling as the organization deals with mounting questions about whether it is as free from conflicted funding and industry-favorable bias as it likes to claim.